ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor‐α
Jeremy B. M. Jowett(Baker Heart and Diabetes Institute), Vance B. Matthews(The University of Western Australia)
Cited by 23
Related Papers
Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy
|Frontiers in Bioscience-Landmark|2022|19